Our Press Releases | Association for Accessible Medicines

FDA - Nomination of Dr. Stephen Hahn to FDA

Nov 1, 2019 | Rachel Schwartz

AAM Statement on Nomination of Dr. Stephen Hahn to FDA

AAM Statement on 2019 FDA Drug Shortages

Oct 29, 2019 | Rachel Schwartz

AAM Statement on 2019 FDA Drug Shortages Task Force Report

Oct 23, 2019 | Rachel Schwartz

AAM Launches #DoesntAddUp Ad Campaign to Bring Down Prescription Drug Costs for Patients in the U.S.

Oct 16, 2019 | Rachel Schwartz

AAM Reaction to FDA Statement on Patient Access to Generic Drugs

California State Capitol - AB 824

Oct 8, 2019 | Rachel Schwartz

AAM Response to CA Governor Newsom Signing AB 824

Sep 20, 2019 | Rachel Schwartz

Seniors Denied Access to New, Lower-Priced Generic Drugs Due to Medicare Coverage Delays

Jul 23, 2019 | Rachel Schwartz

AAM Applauds Senate Finance’s Meaningful Effort to Reduce Drug Prices for America’s Patients

Jul 2, 2019 | Rachel Schwartz

National Survey Finds Significant Voter Opposition to Patent Settlement Legislation

Biosimilars

Jun 26, 2019 | Rachel Schwartz

AAM Applauds Sens. Cornyn and Blumenthal’s Efforts to Accelerate Access to More Affordable Biosimilar Medicines

Jun 26, 2019 | Jewel Smith

AAM Announces New 2019 Members

May 23, 2019 | Rachel Schwartz

AAM Statement on FTC Report on Patent Settlements

May 21, 2019 | Rachel Schwartz

AAM Statement on House Bills 965, 1499 and 938